Acasă › Cancer de sân › District of Columbia › Washington
Studii clinice pentru Cancer de sân în Washington, DC
46 studii pentru Cancer de sân caută participanți în și în jurul orașului Washington (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
În curs de recrutareStudiu observațional
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
The Vanguard Study: Testing a New Way to Screen for Cancer
În curs de recrutareVoluntari sănătoși bineveniți
- Walter Reed National Military Medical Center, Bethesda · La 7 mi distanță
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
În curs de recrutareFaza 3
- Georgetown University Medical Center, Washington D.C.
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
În curs de recrutareFaza 2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
În curs de recrutareStudiu observațional
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
În curs de recrutareFaza 3
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Maryland Oncology Hematology P A, Silver Spring · La 7 mi distanță
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · La 7 mi distanță
Genomic Services Research Program
În curs de recrutareStudiu observațional
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Older Breast Cancer Patients: Risk for Cognitive Decline
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Georgetown University, Washington D.C.
Collection of Blood From Patients With Cancer
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
În curs de recrutareFaza 2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
În curs de recrutareFaza 3
- Holy Cross Hospital ( Site 0073), Silver Spring · La 7 mi distanță
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
În curs de recrutareFaza 2
- The George Washington Medical facility Associates, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
În curs de recrutareFaza 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · La 7 mi distanță
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
În curs de recrutareFaza 3
- Georgetown Uni Hospital, Washington D.C.
- Medstar Research Institute, Hyattsville · La 6 mi distanță
Identifying Patterns in the Breath of Individuals With Breast Cancer
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- GW Comprehensive Breast Center, Washington D.C.
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
În curs de recrutareFaza 3
- Georgetown University Medical Center, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
- și încă 1
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
În curs de recrutareFaza 1
- MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center, Washington D.C.
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
În curs de recrutareFaza 1/2
- Georgetown University, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
În curs de recrutareFaza 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · La 7 mi distanță
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
În curs de recrutareFaza 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- și încă 5
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
În curs de recrutareFaza 2
- Georgetown University Medical Center, Washington D.C.
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
În curs de recrutare
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
În curs de recrutare
- Sibley Memorial Hospital, Washington D.C.
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
În curs de recrutareFaza 3
- Sibley Memorial Hospital, Washington D.C.
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
În curs de recrutareFaza 1/2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
În curs de recrutare
- Walter Reed National Military Medical Center, Bethesda · La 7 mi distanță
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
În curs de recrutareFaza 3
- Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital, Washington D.C.
E-Mindfulness Approaches for Living After Breast Cancer
În curs de recrutareFaza 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- și încă 2
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
În curs de recrutareFaza 2
- National Institute of Health Clinical Center, Bethesda · La 7 mi distanță
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
În curs de recrutareFaza 3
- American Oncology Partners, P.A., Bethesda · La 7 mi distanță
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
În curs de recrutareFaza 2
- Georgetown University Medical Center, Washington D.C.
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
În curs de recrutareFaza 3
- MedStar Washington Hospital Center, Washington D.C.
- Maryland Oncology Hematology P.A., Silver Spring · La 7 mi distanță
- Maryland Oncology Hematology P.A., Bethesda · La 7 mi distanță
- și încă 1
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
În curs de recrutareFaza 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- George Washington University Medical Center, Washington D.C.
- și încă 2
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Cancer Support Community Research & Training Institute, Washington D.C.
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
În curs de recrutareFaza 2
- Georgetown University, Washington D.C.
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
În curs de recrutareFaza 2
- George Washington-Medical Faculty Associates, Washington D.C.
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
În curs de recrutare
- Sibley Memorial Hospital, Washington D.C.
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
În curs de recrutareStudiu observațional
- Holy Cross Hospital - Silver Spring, Silver Spring · La 7 mi distanță
- The Center for Cancer and Blood Disorders - Bethesda, Bethesda · La 7 mi distanță
Study in Patients With Breast Cancer Leptomeningeal Metastasis
În curs de recrutareStudiu observațional
- Sibley Memorial Hospital, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Silver Spring · La 7 mi distanță
- Massive Bio SYNERGY-AI site, Bethesda · La 7 mi distanță
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
În curs de recrutare
- Georgetown University, Washington D.C.
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
În curs de recrutareVoluntari sănătoși bineveniți
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
În curs de recrutareStudiu observațional
- Maryland Oncology Hematology, PA, Silver Spring · La 7 mi distanță
- Maryland Oncology Hematology - Bethesda, Bethesda · La 7 mi distanță
CtDNA Based MRD Testing for NAC Monitoring in TNBC
În curs de recrutareStudiu observațional
- George Washington University, Washington D.C.
Studii pentru Cancer de sân în alte orașe
- New York City, NY136 studii
- Houston, TX126 studii
- Boston, MA112 studii
- Nashville, TN81 studii
- Los Angeles, CA73 studii
- Edison, NJ68 studii
- St. Louis, MO64 studii
- Queens, NY64 studii
- Durham, NC64 studii
- Chicago, IL59 studii
- Philadelphia, PA56 studii
- Dallas, TX55 studii
Alte studii în Washington
- Cancer (toate tipurile)58 studii
- Cancer pulmonar cu celule non-pătrate55 studii
- Cancer metastatic43 studii
- Cancer pulmonar41 studii
- Cancer de prostată38 studii
- Obezitate33 studii
- Cancer colorectal29 studii
- Boli cardiovasculare28 studii
- Cancer de vezică urinară26 studii
- Leucemie mieloasă acută24 studii
- Cancer ovarian23 studii
- Limfom23 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.